chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tested positive for Herpes STD/ I have never had a STD in 49 years of living. I have been with the same male partner for 10 years. The . most he does is masturbate daily. I don't have any other partners. I have never had the chicken pox. I took a blood test 2 months prior to the vaccine because I was having knee surgery done and also because my doctor ordered a full workup on me. I have NEVER seen any results come back from the lab as positive for any STD. I have alsways been negative for STD's. NOw, after the 2nd vaccine, a pap smear, and blood workup. I'm positive for Herpes. . I don't even have any symptoms for Herpes. No blisters anywhere, no cold sores anywhere, nothing. No fevers, no chills.
axillary lymph node swelling, body aches and supraclavicular lymph node tenderness
felt weak; Nauseated; unable to sleep; was sick for about 2 hours; got so cold and couldn't get warm/felt cold to her bones; This is a spontaneous report from a contactable consumer (patient herself). A 64-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunisation. There were no medical history and concomitant medications.  Investigation assessment was no. Caller received the Covid-19 vaccine Monday (21Dec2020). She was sick for 2 hours yesterday (22Dec2020). She got so cold and couldn't get warm, after a while she felt better. She felt cold to her bones. Today (23Dec2020) she felt weak and was nauseated. She worked at hospital. She was a tech at the hospital. She was a frontline worker. When a vial became available, she was given the vaccine. She was also unable to sleep last night (22Dec2020). She was up most of the night.  She clarified that when she said she was sick for about 2 hours she was referring to being cold. Outcome of cold was recovered on 22Dec2020, and outcome of other events were unknown.   Information on the lot/batch number has been requested.
I know one person who died after the 2nd Pfizer COVID vaccine; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID.  A female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose: 1 MANUFACTURER UNKNOWN), for COVID-19 Immunization.The following information was reported: DEATH (death, medically significant), outcome "fatal", described as "I know one person who died after the 2nd Pfizer COVID vaccine". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed.Clinical information: Reporter know one person who died after the 2nd Pfizer Covid vaccine and another who will be on anti-seizure medicine for the rest of their lives after taking the 2nd vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: I know one person who died after the 2nd Pfizer COVID vaccine
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 4:12 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 4:12 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 38.10.  Concomitant products were not provided.  Excursion time was 09 AM temperature was 34 total doses given for the day was 188, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 06-Apr-2021, vial was moved to clinic on 15-Apr-2021. 18 vials were sent to clinic. Vaccine BUD date was 09-May-2021.  On 15-Apr-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 34, 10 AM: 36, 11 AM: 38, 12 AM: 39, 1PM: 43, 2 PM: 44, 3 PM: 44, 4 PM: 42 and 5 PM: 42.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
I have taken flu shots for years. I always drink lots of water (average- 8 glasses daily). Let me preface this report by saying that I've never had adverse effects with flu shots before this year's combination Flu-H1N1 shot. I am 63 years old. I do not take any prescription drugs - I take only vitamins. In 2008, I even took a flu shot and a pneumonia shot at the same time and had no problem. Last year (2009), I took a flu shot and then a few weeks later the H1N1 shot and had no problem.  Day 1 - Friday, Oct 22, 2010 - Health Center I take the combination Flu-H1N1 shot at 8:30 a.m. I notice I am testy and on edge from 11 am-4 pm and have worsening muscle pain throughout my body and very upset stomach (hard and gassy stomach).  I notice constipation along with other symptoms from 4-7 pm. Extreme body chills set in from 7-9 pm and I go to sleep. I wake up at 9:30 pm in a cold sweat, stomach ache and so dizzy that I nearly faint. Escaping air from rectum and burping revives me and I recover from dizziness and cold sweats.  Day 2 - Oct. 23 Less muscle pain but still very sore, I feel on edge, very light-headed and bad headache. Stomach still feels hard and gassy and still constipated (strange since I usually have a bowel movement twice daily). At 4 pm, I start belching which relieves some of the stomach gas and headache lessens.  Day 3 & 4 - Oct 24/25 Still constipated, muscles achy, stomach problems and belching - feels like a stomach flu.  Day 5 - Oct 26 Burning in stomach area (upper GI), still feeling on edge, digestive problems and belching, constipation and headache continues.  Day 6 - Oct 27 Finally have a bowel movement and stomach seems to be getting better - less gassy, less belching, less muscle pain but still on edge .  Day 7-10 Oct 28-31 - Stomach feels stronger, headache lessens and seems to leaving out of the top of my head as the days pass.  November 1, 2010 - first day I feel normal
Got Tdap within 15 minutes felt sick. Chest pain. Vomited, lightheadedness - SOB. Pain in chest all the way through to her back. Pulse 150 BP went up. Lasted about 1 hr. (or 45 min). BP went to 140/108. BENADRYL 25mg by mouth tid x 4 days.
Client vaccinated at a drive thru clinic and was in the  waiting area when she complained of SOB and itchy mouth. Client took her own Zyrtec by PO. VSS. Observed for 30 minutes, client denied further issues at that time and declined further medical treatment. EMS was onsite with another issue and assessed client as well. Client wanted to go home and left clinic.
after about 4 hours of being vaccinated ...i have been feeling a mild pain in my heart ...... .that does not go away.......it has been 3 days now .......if  it get worse  i will have to go to the hospital
Two days later (02Sep) I rebounded and tested positive for covid even after having completed my Paxlovid meds (20Aug).; COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Apr2021 as dose 1, single (Lot number: EN8730), in left arm, on 01May2021 as dose 2, single (Lot number: EW0176), in left arm and on 30Dec2021 as dose 3 (booster), single (Lot number: FD7218) at the age of 40 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Bactrim, reaction(s): "Known allergies: Bactrim". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 16Aug2022, outcome "not recovered" and all described as "COVID 19 Treatment"; DISEASE RECURRENCE (medically significant) with onset 02Sep2022, outcome "not recovered", described as "Two days later (02Sep) I rebounded and tested positive for covid even after having completed my Paxlovid meds (20Aug).". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: I rebounded; (16Aug2022) Positive; (02Sep2022) Positive, notes: tested positive for covid even after having completed my Paxlovid meds. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Patient received Paxlovid (Antiviral, Lot number: unknown) from 16Aug2022 to 21Aug2022 for COVID-19 treatment. Patient received other medication in 2 weeks was Coldeeze (Mylan consumer healthcare) from 14Aug2022 to 15Aug2022, Vitamin C from 11Aug2022 to 15Aug2022 and Vitamin D from 11Aug2022 to 15Aug2022. Patient had a lingering cough since testing positive initially on 16Aug2022. Patient was started getting intermittent headaches again on 30Aug2022 after almost two weeks of being okay. Two days later (02Sep2022) patient rebounded and tested positive for covid even after having completed my Paxlovid meds (20Aug2022).
I immediately was sick. The fluid entered and it felt like it traveled. The feeling was like bees stinging me. My arm swelled right away. I was kept for forty five minutes to ensure no swelling of mouth. Went home. Within hours could not walk. My joints were so painful. Rash. 105 temperature. Called Public Health and was told ALL NORMAL. After ten days I was better but not great. I could participate in life but my bladder was not working and I just hurt. Three weeks later at 8:30pm it all came rushing back. The bees stinging. The rash. My chest was on fire.My heart raced. The internal vibrations were overwhelming.
My menstrual cycle disappeared for 93 days following my second Moderna vaccination. My first vaccination was on March 18, 2021 and I had a menstrual cycle March 29-April 1. After my second vaccination on April 17, 2021 I didn't have another menstrual cycle until June 30, so 93 days from my previous cycle. My cycle typically averages about 32 to 35 days in between. I have had two cycles since the one on June 30 that were 34 and 35 days respectively, but my current cycle is already 44 days and has not shown up yet, don't know if this could be a lingering result - that my cycle has become more inconsistent.
MD reported pt initially vac. w/ MMR live at 15 mo's was vac. w/ booster MMR on 10-20-89 along w/ DTP.  Pt died 10-25-89.  Autopsy = overwhelming strep. sepsis.  MD and autopsy pathologist felt pt death not related to vaccination.
Narrative: Rash, ErythemaMultiform & UrticariaPruritus
Information has been received from a registered nurse referring to 2 patients of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. On 23-SEP-2015, the patients were vaccinated with ZOSTAVAX (0.67 ml, Lot #L024997, expiration date: 06-OCT-2016), which were improperly stored for 9 days. The outcome was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Metallic taste in mouth shortly after shot.  Food and drink tastes bad.  Just wanted to report side effect.
high fever of 102°F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (high fever of 102°F) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 24-Nov-2020.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PYREXIA (high fever of 102°F). At the time of the report, PYREXIA (high fever of 102°F) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MOD21-059974 (E2B Linked Report).; Sender's Comments:  MOD21-059974:Crosslink
I had a big relapse in my chronic fatigue and could barely get off of my couch. It lasted about 3-4 works.
Patient developed painful rash on buttocks and right perineal area. The rash on the buttocks were vesicles with erythematous base at sacral dermatome S3-S5. The perineal rash is on the right labia majora - confluent ulcerations with necrotic base and S2 dermatome. All lesions appear herpetic.
swelling; red; hard; itching; finger joints swelled; finger joints painful; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), ERYTHEMA (red), INDURATION (hard), PRURITUS (itching) and PERIPHERAL SWELLING (finger joints swelled) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to chemicals (They cause itching), Dairy intolerance and Gluten intolerance.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced SWELLING (swelling), ERYTHEMA (red), INDURATION (hard), PRURITUS (itching), PERIPHERAL SWELLING (finger joints swelled) and ARTHRALGIA (finger joints painful). At the time of the report, SWELLING (swelling), ERYTHEMA (red), INDURATION (hard), PRURITUS (itching), PERIPHERAL SWELLING (finger joints swelled) and ARTHRALGIA (finger joints painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
This spontaneous report as received from a physician refers to two unspecified patients of unknown age and gender. On unknown dates, the patients were inadvertently vaccinated with two doses of improperly stored ZOSTAVAX vial (lot # K010732, expiration date 10-OCT-2015, dose and route of administration were not reported). No adverse effects were reported. Product quality complaint (PQC) was not involved. Additional information has been requested.
Severe chills, shaking, trembling, unable to feel warm. Severe body aches. Lethargy.
Janseen-Covid 19- EUA  Shortly after pt got Janseen vaccination he felt a sudden in onset of dizziness with possible syncopal episode.  Pt states he has very poor intake decrease oral intake with increase of nicotine.  pt states he has had this happen after getting a shot before. 911 was activated and ama signed with fire department.
This case was reported by a nurse via call center representative and described the occurrence of adverse event in a patient who received FLUARIX quadrivalent (batch number 3L9Ld, expiry date 16th June 2016). In 2015, the patient received FLUARIX quadrivalent. On an unkonwn date, an unkonwn time after receiving FLUARIX quadrivalent, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown. Additional detials were provided as follows: The office reported 3 separate adverse events for the vaccine. The nurse reported 2 of the adverse events via fax to VAERS but did not report the 3rd event because of some type of non-traditional treatment. This case has been link to 2 other cases (US2015151593 and US2015151595), reported by the same reporter.
46 y/o patient who received AVA (1) in his left arm on 6 APR 2013. That evening he noted what he describes as a "mottled rash" surrounding the vaccination accompanied by pain, itching, redness and swelling. He did not have upper extremity weakness, and his symptoms did not restrict his duties. He denies experiencing angioedema, itching or swelling of tongue, difficulty swallowing, hives, dyspnea, and nasal symptoms. He did not self treat and his symptoms resolved in about 2 days. His physician partner, evaluated his reaction and recommended an anthrax vaccine exemption. Patient reported feeling well day of and prior to vaccinations. No known exposures. No other vaccines received on 6 APR. No history of prior vaccine reactions.
09/19/02- At 6 pm, one eye became swollen then within minutes both eyes swollen shot, Seen by PMD, 9/20/02, Rash all over body, no fever. Follow up: No site reaction.  Premedicated motrin and benadryl.  Pediatrician diagnosis: vaccine reaction.
Left arm - itchy, some swelling, redness, tender, a few blisters. Symptoms started developing around 7pm on 11/20/17. Decided on course of treatment to be BENADRYL and a cold compress and then watchful waiting.
will give Adacel to a 75 year old female patient; Initial information received on 26-Apr-2019 regarding an unsolicited valid non-serious case received from a pharmacist via phone.  This case involves a 75 years old female patient who was vaccinated with a dose of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (Information on the batch number was requested, expiry date, dose, dose in series, route and site of administration were not reported) on an unknown date.  The patient's past medical history included Rubber sensitivity.  Concomitant medications were not reported.   It was a case of actual medication error due to inappropriate age at vaccine administration.  It was unknown if any adverse event occurred or not following the vaccination.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.   Documents held by the sender: none.
Injection site discomfort; This case was reported by a nurse via call center representative and described the occurrence of injection site discomfort in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced injection site discomfort. On an unknown date, the outcome of the injection site discomfort was recovered/resolved.   It was unknown if the reporter considered the injection site discomfort to be related to Shingrix.  Additional details were provided as follows: The reporter consent to follow up. For tolerance of 2nd dose, refer case US2019AMR199259. The case has been linked to the cases US2019AMR199264 and US2019AMR199268, reported by same reporter.
Patient was given flu vaccine in right deltoid muscle. Approximately 1 minute later patient fainted. She was responsive approximately 5 seconds after she fainted. Patient was stable after event. Her father was notified and was brought to the ED for evaluation.
This was my second shot.  Just for background, my reaction to the FIRST SHOT was minimal (slight headache) until the 2 WEEK mark (after my checkin) when all of a sudden I had **5 canker sores in my mouth (both cheeks/ NOT cold sores) and also a ** buzzing in my ear.   I received my second shot on 3/26/21 .. minimal reaction except sore arm - until 2 WEEKS exactly (again.. and after check in).   ****Enlarged inguinal lymph node on right side with pain and sleeplessness.   Over an inch... maybe the size of a pecan in its shell??  No sign of infection - as far as I can tell - no urinary burning or pain.  no extra discharge, etc.. no cuts.   also, continued buzzing in ears and sores on tongue and lips - all at the 2 week mark.   FYI, the enlarge lymph node, ear buzzing and multiple canker sores are highly unusual for me!!
Information has been received from a physician who reported that a mother chose to stop her daughter's GARDASIL due to "bad press". The article was in newspaper on 29-OCT-2009 concerning three girls, known as the "GARDASIL Girls" had experiences after receiving the vaccine. On an unspecified date the patient who was vaccinated with a dose of GARDASIL (lot # not reported). On an unspecified date she experienced charley horse, spasms and pain in muscles with fainting, nausea, irregular heartbeat and rash since she received GARDASIL. Now she was using a wheelchair. The patient's outcome was not reported. Upon internal review, using wheelchair was considered to be disabling. This is one of three reports from the same source. No additional information is available.
Pt received #1 MENACTRA 7/28/14. Developed hives at site 3 days later. Hives progressed next day. Went to ED 8/3/14. Received prednisone and BENADRYL. As of 5/4/14 still with some hives.
At 12.15 I went into atrial fibrillation for 6 hours. I took an extra digoxin. The following Wednesday I had fever and continue to have fever 3 days later.
Fever, chills, headache, earache, joint pain, minor swallowing problem within 12-24 hours of receiving Tetanus vaccine.
This was a 2nd booster administered on 6/2/2022. The patient has a history of seizures. On 6/3 at 6:30am, the patient went into status epilepticus without relief from PRN rescue medications. Was sent to ER with elevated temperature. Treated in ER with IV hydration and IV antibiotics. At time of this report, patient is still in the hospital.
About one month after receiving the vaccine I started to have itchy skin, and I developed red tiny spots on my skin. The spots were on my right and left arms, thighs, hands, chest and on my face. They eventually turned into warts on my left forearm and right trapezius. I went in to see a dermatologist, and they removed the two warts I had. I was told the skin rash developed due to a virus. I was given a cream called fluocinonide to use to help with the itching.
Client is a 14 year old female who received her 1st dose of the COVID-19 vaccine Pfizer to left deltoid at 10:33 am.  Client observed in observation area complaining of nausea, headache, tremors.  Client denies any pain or discomfort to vaccination site.  Client encouraged to rest and relax. Fire Rescue arrived to scene for further evaluation.  Vital signs: BP:107/69, R arm, HR: 68, RR 18, O2 Sat: 98% via room air, temp: 98.7, EKG: normal sinus.  Client verbalized nausea and tremors have reduced but headache persists.  Client refused to be transported to the hospital and left the observation area at 11:15 am.